Clinical Trial Update: Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines [Phase 1]

View source ↗

Summary

Phase I open-label trial evaluating the Bacillus Calmette-Guérin (BCG) vaccine in combination with tuberculosis drugs and vaccines; the study is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) vaccine (Bacillus Calmette-Guérin vaccine)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED | Results posted: 2025-03-25